F19.14
Other psychoactive substance abuse with psychoactive substance-induced mood disorder
Clinical Classification Guidelines
Inclusion Terms
- Other (or unknown) substance use disorder, mild, with other (or unknown) substance-induced bipolar or related disorder
- Other (or unknown) substance use disorder, mild, with other (or unknown) substance-induced depressive disorder
Medical Intelligence & Overview
ICD-10 Code F19.14 refers to a condition where a person misuses psychoactive substances, which are chemicals that affect the brain and can alter mood, perception, and behavior. In this specific case, the substance abuse is accompanied by a mood disorder caused or triggered by the substance use, such as depression or bipolar-like symptoms. This diagnosis highlights the complex interaction between substance use and mental health, emphasizing the importance of comprehensive evaluation and treatment.
Causes & Symptoms
Clinical Causes: Misuse of psychoactive substances such as alcohol, drugs, or medications not prescribed by a healthcare provider. Underlying mental health issues that increase vulnerability to substance use as a form of self-medication. Environmental factors, including stress, peer influence, or traumatic experiences that lead to substance misuse. Genetic predisposition affecting both substance use behaviors and mood regulation. Chronic or prolonged use of psychoactive substances, leading to changes in brain chemistry that affect mood and behavior.
Key Symptoms: Changes in mood, including feelings of depression, euphoria, or irritability. Depressive symptoms such as persistent sadness, loss of interest, or fatigue. Episodes resembling bipolar disorder, with alternating periods of high energy and low mood. Altered behavior and thoughts, including impulsivity or risky actions. Physical signs of substance misuse like tremors, dilated pupils, or impaired coordination.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive assessment by a healthcare professional, including a detailed medical and psychological history, physical examination, and possibly laboratory tests. The clinician considers the pattern of substance use, timing relative to mood symptoms, and whether other underlying psychological conditions are present. Psychiatry evaluation helps determine if the mood disturbances are directly related to substance use or if they represent co-occurring mental health conditions.
Treatment Protocols: Treatment strategies focus on addressing both the substance use disorder and the associated mood disorder. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is F19.14 a billable ICD-10 code?
Yes, F19.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.14?
Clinical documentation must specify the nature of Other psychoactive substance abuse with psychoactive substance-induced mood disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference